Cell-derived particles presenting heterologous cd24 and use thereof in therapy
AssigneeIchilov Tech Ltd.
InventorsNadir ARBER, Shiran SHAPIRA
Life of this patent
Estimating the term…
Abstract
A method of producing cell derived particles is disclosed. The method comprising isolating cell-derived particles from a biological sample comprising cells modified to present CD24 so as to obtain a preparation of the cell-derived particles substantially devoid of intact cells. Cell derived particles, a culture medium and a cell culture are also disclosed.
Claims20
A method of treating a coronavirus infection in a subject in need thereof, the method comprising:
- (a) isolating cell-derived particles from a biological sample comprising cells modified to present CD24 so as to obtain a preparation of the cell-derived particles substantially devoid of intact cells;
- and
- (b) administering to the subject a therapeutically effective amount of the preparation of the cell-derived particles,
- thereby treating the coronavirus infection in the subject.
A method of treating or preventing a cytokine storm syndrome in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising exosomes presenting heterologous CD24 on their surface, wherein said exosomes are obtained from cells genetically modified to present said CD24, and wherein the composition is substantially devoid of intact cells, thereby treating or preventing the cytokine storm syndrome in the subject.
Dependencies are inferred from the claim text.